Alternative Contraceptive Options for Patients Intolerant to Mirena
The copper IUD is the most appropriate first-line alternative for a patient who cannot tolerate Mirena, offering equally effective hormone-free contraception with no systemic hormonal side effects. 1, 2
Primary Recommendation: Copper IUD
The copper IUD provides several distinct advantages for sensitive patients:
- Highly effective contraception with failure rates less than 1% per year, comparable to Mirena and effective for 10-12 years 2, 3
- Completely hormone-free, eliminating all systemic progestin effects that may have caused intolerance to Mirena 2, 3
- No increased thrombotic risk, making it ideal for patients with any thrombotic risk factors 1, 2
- Safe for immunocompromised patients and those on immunosuppressive therapy, with no increased infection risk 1, 2
- Immediate return to fertility upon removal with no waiting period 2
Important Caveats for Copper IUD
The copper IUD does have specific side effects that differ from Mirena:
- Increased menstrual bleeding and cramping, particularly during the first several months after insertion 1, 2, 3
- This is the opposite effect of Mirena, which typically reduces bleeding 3, 4
- Small increased infection risk only during the first 20 days post-insertion, not beyond 2, 3
Secondary Hormonal Alternatives
If the patient requires hormonal contraception but cannot tolerate the levonorgestrel IUD specifically, consider these options in order of effectiveness:
Etonogestrel Subdermal Implant (Nexplanon)
- Highest contraceptive efficacy among reversible methods, effective for 3 years 2, 5
- Different progestin (etonogestrel vs. levonorgestrel) may be better tolerated if sensitivity was progestin-specific 5
- Minimal to no bone loss, unlike depot medroxyprogesterone 2
- Common pitfall: May interact with efavirenz-based antiretroviral therapy, reducing efficacy 1
Progestin-Only Pills
- Lower efficacy than IUDs or implants, requiring strict daily adherence 1, 2
- No increased VTE risk, appropriate for patients with thrombotic contraindications 1
- May be better tolerated than Mirena if local uterine effects (not systemic progestin) caused intolerance 1
- Important limitation: Effectiveness depends entirely on consistent daily use 1
Depot Medroxyprogesterone Acetate (DMPA/Depo-Provera)
- Typical failure rate approximately 6%, administered every 12 weeks 2
- Black box warning for decreased bone density with prolonged use 1, 2
- Not recommended for patients with thrombotic risk factors or those at risk for osteoporosis 1
- Should be avoided in patients on chronic glucocorticoids or with underlying bone disease 1
Contraindicated Options
Combined hormonal contraceptives (pills, patches, rings) should be avoided in patients with:
- History of thrombosis or thrombotic risk factors 1
- Positive antiphospholipid antibodies 1
- Active SLE with moderate-severe disease activity 1
- Age >35 years who smoke 6
- Uncontrolled hypertension 6
The VTE risk with combined hormonal contraceptives is 36 times higher than baseline, with odds ratios ranging from 2.2 to 6.6 depending on progestin type 1
Clinical Decision Algorithm
Step 1: Determine the specific reason for Mirena intolerance:
- If hormonal side effects (acne, mood changes, headaches): Consider copper IUD 2, 3
- If local uterine effects (cramping, spotting): Consider etonogestrel implant or progestin-only pills 2, 5
- If device-related discomfort: Consider progestin implant or oral methods 2
Step 2: Assess contraindications:
- Thrombotic risk factors present: Copper IUD, progestin-only pills, or etonogestrel implant 1, 2
- Osteoporosis risk or chronic steroid use: Avoid DMPA 1, 2
- Heavy menstrual bleeding: Avoid copper IUD, consider etonogestrel implant 2, 3
Step 3: Consider patient preferences: